Report - NDA 020763/S-001, 002, and 010 Page 3 · 2.3 Dosage Adjustment in Patients With Hepatic Impairment . 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS .

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form